Banner

Article

Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics

Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.

Related Videos
Related Content
© LALAKA - stock.adobe.com
January 14th 2025

A special report on AI in primary care from Annals of Family Medicine

Ep. 47: Weight loss drugs with Robert Kushner, MD
January 13th 2025

Ep. 47: Weight loss drugs with Robert Kushner, MD

© Dragana Gordic - stock.adobe.com
January 14th 2025

Physicians can expect to see twice as many patients with dementia by 2060

Ep. 46: Social media health information with Richard Miller, MD
January 6th 2025

Ep. 46: Social media health information with Richard Miller, MD

© Joelle Kaufman
January 14th 2025

The first line of defense: How primary care doctors can guide patients through a cancer diagnosis

© Dz Lab - stock.adobe.com
January 14th 2025

Americans may be twice as likely to be diagnosed with dementia than previously believed; biosensing platform that can detect nucleic acids; the effect of medical marijuana laws on opioid use outcomes – Morning Medical Update